BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Zhao Y, Shao H, Zheng X. Metabolic and endocrinal effects of N-desmethyl-olanzapine in mice with obesity: Implication for olanzapine-associated metabolic changes. Psychoneuroendocrinology 2019;108:163-71. [PMID: 31302499 DOI: 10.1016/j.psyneuen.2019.06.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Lis M, Stańczykiewicz B, Liśkiewicz P, Misiak B. Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics. Psychoneuroendocrinology 2020;119:104744. [DOI: 10.1016/j.psyneuen.2020.104744] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
2 Miron IC, Popescu F, Enăchescu V, Cristea OM, Stoicănescu EC, Amzoiu E, Amzoiu M, Popescu FD. Combination of Olanzapine Pamoate with Melatonin and Metformin: Quantitative Changes in Rat Adipose Tissue. Curr Health Sci J 2019;45:372-82. [PMID: 32110439 DOI: 10.12865/CHSJ.45.04.05] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 An H, Fan H, Chen S, Qi S, Ma B, Shi J, Wang Z, Yang F. Effects of Dose, Age, Sex, Body Weight, and Smoking on Plasma Concentrations of Olanzapine and N-desmethyl Olanzapine in Inpatients With Schizophrenia. J Clin Psychopharmacol 2021;41:255-9. [PMID: 33814547 DOI: 10.1097/JCP.0000000000001390] [Reference Citation Analysis]
4 An H, Fan H, Yun Y, Chen S, Qi S, Ma B, Shi J, Wang Z, Yang F. Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia. Front Psychiatry 2022;13:930457. [DOI: 10.3389/fpsyt.2022.930457] [Reference Citation Analysis]